Literature DB >> 7251537

Human pharmacokinetics and CSF penetration of clavulanic acid.

R Münch, R Lüthy, J Blaser, W Siegenthaler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7251537     DOI： 10.1093/jac/8.1.29

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

2.  Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination.

Authors:  D Adam; I de Visser; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.

Authors:  G Witkowski; H Lode; G Höffken; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1982-08       Impact factor: 3.267

Review 4.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 5.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

6.  Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model.

Authors:  Abraham Ochoa-Aguilar; Rosa Ventura-Martinez; Marco Antonio Sotomayor-Sobrino; Ruth Jaimez; Ulises Coffeen; Ariadna Jiménez-González; Luis Gerardo Balcázar-Ochoa; Rafael Pérez-Medina-Carballo; Rodolfo Rodriguez; Ricardo Plancarte-Sánchez
Journal:  J Pain Res       Date:  2018-05-21       Impact factor: 3.133
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.